Sanuwave Health Logs Record Q1 Revenue and Increased Consumables Utilization
Sanuwave Health reported record first-quarter revenue and rising consumables utilization in Q1 2026, driven by renewed advanced wound care demand. Management said the advanced wound care market began recovering after a difficult start tied to skin substitute reimbursement changes.
1. Q1 Financial Performance
Sanuwave Health delivered record revenue in Q1 2026, marking its highest quarterly sales ever. Management credited the surge to stronger product adoption across key markets and an uptick in procedure volumes.
2. Consumables Utilization Growth
Consumables utilization rose notably as clinics resumed advanced wound care procedures, boosting sales of Sanuwave’s proprietary consumables. Rising procedure volumes translated into a higher attach rate per device, enhancing overall revenue mix.
3. Market Recovery and Outlook
Executives noted that the advanced wound care market began to rebound after early-year headwinds from skin substitute reimbursement shifts. Management expressed confidence that stabilizing reimbursement policies will support sustained growth in upcoming quarters.